Measures average blood glucose over 3 months. Key marker to assess how well GLP-1 therapy is controlling diabetes.
Medication education
GLP-1 receptor agonists for type 2 diabetes and weight management.
Ojava organizes labs, weight trends, and questions to help you prepare for conversations about GLP-1 medications with your clinician. This is general educational information, not medical advice.
What are GLP-1 receptor agonists?
A class of medications that help manage type 2 diabetes and support weight loss.
Drug class: GLP-1 receptor agonists are a class of medications that mimic a natural hormone that regulates blood sugar and appetite.
What they do: GLP-1 medications help your pancreas release insulin in response to high blood sugar, slow digestion, and help you feel full longer. These actions lower blood glucose and may support weight loss.
FDA-approved uses: Type 2 diabetes management and weight loss in people with obesity or overweight. Common brand names include Ozempic, Wegovy, Mounjaro, and others.
Labs commonly tracked
Ojava organizes these markers to show your progress on GLP-1 therapy.
Shows baseline blood sugar before meals. Tracked to assess GLP-1 effectiveness at controlling morning glucose.
GLP-1 medications are known to support weight loss. Regular weight tracking helps monitor this effect.
Important to monitor kidney health while on GLP-1 therapy, especially in people with diabetes.
Often tracked alongside GLP-1 therapy for overall cardiovascular health assessment.
Periodic monitoring helps ensure safe use of GLP-1 medications.
Questions to discuss
Prepared topics for your visit.
How is my A1c trending on this GLP-1 medication?
Are there any side effects I should monitor or report?
Should I adjust my diet or exercise while on a GLP-1 medication?
How often should I get labs checked?
Are there any interactions with other medications I am taking?
What signs would indicate I need to pause or stop this medication?